We further demonstrate that the relative abundance of both PSA−/lo and PSA+ PCa cells in tumors are regulated dynamically by systemic androgen levels, which in turn impacts tumor regeneration and growth in androgen-proficient versus androgen-deficient conditions. This evidence concerns the gene KLK3 and neoplasm.